Amid psychedelic therapy's legalization in Colorado, veterans implored Colorado Springs officials not to pass treatment ...

Neumora Therapeutics Inc. (NASDAQ: NMRA) nosedived by more than 80 percent during pre-market trading following disappointing ...

Launched this year, Miami-based Hope Therapeutics is a developer of NRX-100, a ketamine drug used to treat suicidal ...

Neumora Therapeutics shares plunged more than 80% on Thursday after its lead drug candidate failed to help patients with depression in a study. The drug, called navacaprant, was no better than a ...

Navacaprant is the company's main product candidate, and was measured using the Montgomery-Åsberg Depression Rating Scale, or MADRS, a 10-question diagnostic questionnaire used by mental-health ...

Neuroscience drug developer Neumora Therapeutics released highly anticipated results from the first of three Phase 3 trials ...

In a statement, Neumora revealed that the KOASTAL-1 study missed its primary endpoint, with navacaprant failing to achieve a ...

In a highly anticipated readout for the kappa opioid receptor class in major depressive disorder, Neumora’s navacaprant ...

The study, first of the three late-stage trials, was testing the drug, navacaprant, in patients with major depressive ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Even the coroner specified that the self-inflicted death was an “adverse effect” of the antidepressant the man had been ...